Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of neural transmission

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00702-011-0676-8PMID 21695417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells

  2010cited by this paper
• Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion.

  2010cited by this paper
• Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington’s disease

  2010cited by this paper
• Blood levels of kynurenines, interleukin‐23 and soluble human leucocyte antigen‐G at different stages of Huntington’s disease

  2010cited by this paper
• IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis

  2010cited by this paper
• On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio

  2010cited by this paper
• Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review).

  2010cited by this paper
• The Role of Tryptophan Catabolism along the Kynurenine Pathway in Acute Ischemic Stroke

  2010cited by this paper
• Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction

  2010cited by this paper
• Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity*

  2010cited by this paper
• Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

  2010cited by this paper
• Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis

  2009cited by this paper
• Polyglutamine disruption of the huntingtin exon1 N-terminus triggers a complex aggregation mechanism

  2009cited by this paper
• HLA-G: a human pregnancy-related immunomodulator.

  2009cited by this paper
• Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway.

  2009cited by this paper
• Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.

  2009cited by this paper
• Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.

  2008cited by this paper
• Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment*

  2008cited by this paper
• Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages.

  2008cited by this paper
• Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity

  2008cited by this paper
• Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds

  2008cited by this paper
• Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease

  2008cited by this paper
• In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease

  2008cited by this paper
• A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

  2008cited by this paper
• IDO: a double-edged sword for T(H)1/T(H)2 regulation.

  2008cited by this paper
• Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments

  2008cited by this paper
• Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats

  2007cited by this paper
• Characterization of the Kynurenine Pathway in Human Neurons

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.

  2007cited by this paper
• Altered kynurenine metabolism correlates with infarct volume in stroke

  2007cited by this paper
• HLA-G in the nervous system.

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain.

  2007cited by this paper
• Role of inflammation and cellular stress in brain injury and central nervous system diseases

  2006cited by this paper
• Inflammation in stroke and focal cerebral ischemia.

  2006cited by this paper
• Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis

  2006cited by this paper
• Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.

  2006cited by this paper
• KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENT

  2006cited by this paper
• Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.

  2006cited by this paper
• Inflammation in adult and neonatal stroke.

  2006cited by this paper
• Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice.

  2006cited by this paper
• Tryptophan metabolism and oxidative stress in patients with chronic brain injury

  2006cited by this paper
• Differential effects of the tryptophan metabolite3‐hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines

  2006cited by this paper
• Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.

  2005cited by this paper
• A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo.

  2005cited by this paper
• Role of kynurenines in the central and peripheral nervous systems.

  2005cited by this paper
• Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway Inhibition

  2005cited by this paper
• Tryptophan metabolism and oxidative stress in patients with Huntington's disease

  2005cited by this paper
• Indoleamine 2,3 dioxygenase and human leucocyte antigen‐G inhibit the T‐cell alloproliferative response through two independent pathways

  2005cited by this paper
• Age-Related Increase of Kynurenic Acid in Human Cerebrospinal Fluid – IgG and β2-Microglobulin Changes

  2005cited by this paper
• Studying the immunosuppressive role of indoleamine 2,3‐dioxygenase: tryptophan metabolites suppress rat allogeneic T‐cell responses in vitro and in vivo

  2005cited by this paper
• Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

  2005cited by this paper
• An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease

  2005cited by this paper
• Linking Two Immuno-Suppressive Molecules: Indoleamine 2,3 Dioxygenase Can Modify HLA-G Cell-Surface Expression1

  2005cited by this paper
• Inflammatory response after acute ischemic stroke.

  2005cited by this paper
• A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

  2005cited by this paper
• Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.

  2005cited by this paper
• Tryptophan Loading Induces Oxidative Stress

  2004cited by this paper
• Neopterin to Monitor Clinical Pathologies Involving Interferon-γ Production

  2004cited by this paper
• Neopterin: a Mediator of the Cellular Immune System

  2004cited by this paper
• Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.

  2004cited by this paper
• Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects.

  2003cited by this paper
• Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects

  2003cited by this paper
• Huntingtin aggregation and toxicity in Huntington's disease.

  2003cited by this paper
• Electrochemical and in vitro evaluation of the redox-properties of kynurenine species.

  2003cited by this paper
• Immune activation and degradation of tryptophan in coronary heart disease

  2003cited by this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cited by this paper
• Immunologic Alterations in Schizophrenia: Neopterin, L-Kynurenine, Tryptophan and T-Cell Subsets in the Acute Stage of Illness

  2002cited by this paper
• Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

  2002cited by this paper
• Tryptophan Metabolites as Scavengers of Reactive Oxygen and Chlorine Species

  2002cited by this paper
• Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

  2002cited by this paper
• The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

  2001cited by this paper
• The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

  2001cited by this paper
• Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest.

  2001cited by this paper
• Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain

  2001cited by this paper
• Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture.

  2001cited by this paper
• Increased kynurenic acid in the brain after neonatal asphyxia.

  2001cited by this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cited by this paper
• Brain ischemia and reperfusion: molecular mechanisms of neuronal injury.

  2000cited by this paper
• Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences.

  2000cited by this paper
• 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction.

  2000cited by this paper
• Role of kynurenines in the neurotoxic actions of kainic acid

  2000cited by this paper
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000cited by this paper
• Early kynurenergic impairment in Huntington's disease and in a transgenic animal model.

  2000cited by this paper
• Transgenic models of Huntington's disease.

  1999cited by this paper
• 3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

  1999cited by this paper
• Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.

  1999cited by this paper
• Impaired synaptic plasticity in mice carrying the Huntington's disease mutation.

  1999cited by this paper
• Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.

  1999cited by this paper
• Kynurenine Hydroxylase Inhibitors Reduce Ischemic Brain Damage: Studies with (m-Nitrobenzoyl)-Alanine (mNBA) and 3,4-Dimethoxy-[-N-4-(Nitrophenyl)Thiazol-2YL]-Benzenesulfonamide (Ro 61-8048) in Models of Focal or Global Brain Ischemia

  1999cited by this paper
• Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.

  1999cited by this paper
• Huntingtin aggregates may not predict neuronal death in Huntington's disease

  1999cited by this paper
• Oxidative Stress in Huntington's Disease

  1999cited by this paper
• Clinical experiences with the use of indole-3-pyruvic acid.

  1999cited by this paper
• Huntington aggregates may not predict neuronal death in Huntington's disease.

  1999cited by this paper
• Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

  1999cited by this paper
• Activated Immune System in Patients with Huntington's Disease

  1998cited by this paper
• Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid

  1998cited by this paper
• Prevention of allogeneic fetal rejection by tryptophan catabolism.

  1998cited by this paper

• Establishing a quantitative fluorescence assay for the rapid detection of kynurenine in urine

  2022cites this paper
• Biochemical and dietary functions of tryptophan and its metabolites in human health

  2022cites this paper
• Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation

  2022cites this paper
• Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions

  2022cites this paper
• An integrated cytokine and kynurenine network as the basis of neuroimmune communication

  2022cites this paper
• The utilization of small non‐mammals in traumatic brain injury research: A systematic review

  2021cites this paper
• IDO and Kynurenine Metabolites in Peripheral and CNS Disorders

  2020cites this paper
• IDO activation, inflammation and musculoskeletal disease.

  2019cites this paper
• Variation of Genes Encoding Tryptophan Catabolites Pathway Enzymes in Stroke

  2019cites this paper
• Does kynurenic acid act on nicotinic receptors? An assessment of the evidence

  2019cites this paper
• Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence

  2019cites this paper
• Aryl hydrocarbon receptor modulates stroke-induced astrogliosis and neurogenesis in the adult mouse brain

  2019cites this paper
• Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington’s disease

  2018cites this paper
• Regulation of kynurenine metabolism by a ketogenic diet[S]

  2018influential citation
• Obesity and Cancer: Existing and New Hypotheses for a Causal Connection

  2018cites this paper
• Neuroinflammation and Neurotransmission Mechanisms Involved in Neuropsychiatric Disorders

  2017cites this paper
• Gut Microbial Metabolism in Health and Disease

  2017cites this paper
• Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease

  2017cites this paper
• Association of pre- and early post-transplant serum amino acids and metabolites of amino acids and liver transplant outcome.

  2017cites this paper
• Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevención con Dieta Mediterránea (PREDIMED) Study.

  2017cites this paper
• Role of Adiposity-Driven Inflammation in Depressive Morbidity

  2017cites this paper
• Processus régénératifs du cerveau moyen dorsal chez le poisson zèbre adulte

  2017cites this paper
• Health Benefits of Bovine Colostrum in Children and Adults

  2017cites this paper
• Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.

  2016cites this paper
• Characterisation of the active site of kynurenine 3-monooxygenase

  2016cites this paper
• Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay

  2016cites this paper
• Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

  2016cites this paper
• Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms.

  2016cites this paper
• Kynurenine Pathway Activation in Human African Trypanosomiasis

  2016cites this paper
• Animal Models to Study the Role of Kynurenine Pathway in Mood, Behavior, and Cognition

  2015cites this paper
• Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity

  2015cites this paper
• Prediction of Metabolic Gene Biomarkers for Neurodegenerative Disease by an Integrated Network-Based Approach

  2015cites this paper
• Health Benefits of Tryptophan in Children and Adults

  2015cites this paper
• Obesity‐ and Neuroinflammation‐Associated Mood and Cognitive Disorders

  2015cites this paper
• Neuropsychiatric Comorbidity in Obesity: Role of Inflammatory Processes

  2014cites this paper
• Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance

  2014cites this paper
• L-Kynurenine/Aryl Hydrocarbon Receptor Pathway Mediates Brain Damage After Experimental Stroke

  2014cites this paper
• Structure and mechanism of kynureninase.

  2014cites this paper
• Excitotoxic brain injury in adult zebrafish stimulates neurogenesis and long‐distance neuronal integration

  2014cites this paper
• Convergent and Divergent Pathways Decoding Hierarchical Additive Mechanisms in Treating Cerebral Ischemia–Reperfusion Injury

  2014cites this paper
• Kynurenines and other novel therapeutic strategies in the treatment of dementia

  2013cites this paper
• The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders

  2013cites this paper
• The mysterious case of the C. elegans gut granule: death fluorescence, anthranilic acid and the kynurenine pathway

  2013cites this paper
• Targeted Deletion of Kynurenine 3-Monooxygenase in Mice

  2013cites this paper
• RND multidrug efflux pumps: what are they good for?

  2013cites this paper
• Inflammation‐Mediated Cognitive and Emotional Alterations in Experimental Models of Metabolic Syndrome

  2013cites this paper
• Cambios en la fisiología de Pseudomonas aeruginosa causados por la sobre-expresión del sistema múltiple de bombeo MexEF-OprN

  2013cites this paper
• Determination of Kynurenine and Tryptophan in Human Plasma by Stacking-Micellar Electrokinetic Chromatography

  2013cites this paper
• Altered gene-expression profile in rat plasma and promoted body and brain development by environmental enrichment

  2013cites this paper
• An expanding range of targets for kynurenine metabolites of tryptophan.

  2013cites this paper
• Anthranilate Fluorescence Marks a Calcium-Propagated Necrotic Wave That Promotes Organismal Death in C. elegans

  2013cites this paper
• The biology of death in Caenorhabditis elegans

  2012influential citation
• Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders.

  2012cites this paper
• Brain rust: Recent discoveries on the role of oxidative stress in neurodegenerative diseases

  2012cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS NATURAIS E EXATAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS: BIOQUÍMICA TOXICOLÓGICA

  2011cites this paper